HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enrico Agabiti Rosei Selected Research

Homozygous Familial Hypercholesterolemia

9/2016Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients with High Cardiovascular Risk.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Enrico Agabiti Rosei Research Topics

Disease

7Hypertension (High Blood Pressure)
09/2021 - 07/2005
3Essential Hypertension
10/2017 - 04/2010
2Amyloidosis
01/2015 - 05/2008
1Chronic Disease (Chronic Diseases)
11/2017
1Inflammation (Inflammations)
01/2017
1Vascular System Injuries
01/2017
1Isolated Systolic Hypertension
12/2016
1Infections
11/2016
1Lymphadenopathy
11/2016
1Homozygous Familial Hypercholesterolemia
09/2016
1Cardiovascular Diseases (Cardiovascular Disease)
09/2016
1Hypercholesterolemia
09/2016
1Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
09/2016
1Dyslipidemias (Dyslipidemia)
09/2016
1Familial Amyloidosis (Hereditary Amyloidosis)
01/2015
1Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2014
1Type 2 Diabetes Mellitus (MODY)
10/2014
1Hypogonadism (Hypergonadotropic Hypogonadism)
05/2008

Drug/Important Bio-Agent (IBA)

3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
12/2014 - 07/2005
2Antihypertensive Agents (Antihypertensives)IBA
09/2021 - 01/2016
2EnalaprilFDA LinkGeneric
10/2017 - 07/2005
2CalciumIBA
12/2016 - 07/2005
2Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2015 - 05/2008
2Nifedipine (Adalat)FDA LinkGeneric
12/2014 - 07/2005
1Biological ProductsIBA
11/2017
1Hydrochlorothiazide (Esidrix)FDA LinkGeneric
10/2017
1lercanidipineIBA
10/2017
1Angiotensin IIIBA
01/2017
1DiureticsIBA
12/2016
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2016
1oxidized low density lipoproteinIBA
09/2016
1alirocumabIBA
09/2016
1evolocumabIBA
09/2016
1CholesterolIBA
09/2016
1LipidsIBA
09/2016
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
12/2014
11,4-dihydropyridine (dihydropyridine)IBA
12/2014
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
12/2014
1Telmisartan (Micardis)FDA Link
12/2014
1Insulin (Novolin)FDA Link
12/2014
1Angiotensin Receptor AntagonistsIBA
12/2014
1aliskirenFDA Link
10/2014
1Ramipril (Altace)FDA LinkGeneric
10/2014
1Retinaldehyde (Retinal)IBA
10/2014
1FlavonoidsIBA
04/2010
1Ethanol (Ethyl Alcohol)IBA
04/2010
1Vasodilator Agents (Vasodilators)IBA
04/2010
1GonadotropinsIBA
05/2008
1Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA
01/2007
1Pharmaceutical PreparationsIBA
07/2005

Therapy/Procedure

2Therapeutics
09/2016 - 01/2007
1Precision Medicine
11/2017
1Length of Stay
11/2016